MORGAN STANLEY PLC/CALL/EDWARDS LIFESCIENCES/120/0.1/16.01.26

MORGAN STANLEY PLC/CALL/EDWARDS LIFESCIENCES/120/0.1/16.01.26 Share Price

DE000MB9UDP3

Real-time Bid/Ask 12:30:08 03/06/2024 pm IST
0.67 ^EUR / 0.71 ^EUR	+4.55%

1 month	+20.00%
3 months	+8.20%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart EDWARDS LIFESCIENCES CORPORATION

Chart MORGAN STANLEY PLC/CALL/EDWARDS LIFESCIENCES/120/0.1/16.01.26

Latest news about EDWARDS LIFESCIENCES CORPORATION

Some of the biggest splits in Corporate America	23/05	RE
Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98	22/05	MT
Edwards Lifesciences : First Quarter 2024 Fact Sheet	15/05	PU
Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86	14/05	MT

More news

Quotes 5-day view

Date	Price	Change
01/24/01	0.66	-10.81%
30/24/30	0.74	+2.78%
29/24/29	0.72	+14.29%
28/24/28	0.63	0.00%
27/24/27	0.63	+8.62%

Delayed Quote Börse Stuttgart

Last update May 01, 2024 at 12:00 am IST

More quotes

Static data

Product type	Warrants
Buy / Sell	CALL
Underlying	EDWARDS LIFESCIENCES CORPORATION
Issuer	Morgan Stanley
WKN	MB9UDP
ISIN	DE000MB9UDP3
Date issued	16/08/2023
Strike	120 $
Maturity	16/01/2026 (593 Days)
Parity	10 : 1
Emission price	0.58 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	1.03 €
Lowest since issue	0.34 €
Delta	0x
Omega	0.000000
Premium	0x
Gearing	18.62x
Moneyness	1.162
Difference Strike	33.11 $
Difference Strike %	+27.59%
Spread	0.04 €
Spread %	5.63%
Intrinsic value	1.788
Present value	-1.097640

Company Profile

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (67.9%); - hemodynamic monitoring systems (15.5%); - other (16.6%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).

Sector

More about the company

Ratings for Edwards Lifesciences Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Consensus: Edwards Lifesciences Corporation

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

86.89 USD

Average target price

96.55 USD

Spread / Average Target

+11.12%

Consensus